Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

• Richarda M. de Voer,

  Affiliations Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, Department of Immunology, University Medical Centre, Utrecht, The Netherlands

  ⨯
• Liesbeth Mollema,

  Affiliation Epidemiology and Surveillance Unit, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Rutger M. Schepp,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Sabine C. de Greeff,

  Affiliation Epidemiology and Surveillance Unit, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Pieter G. M. van Gageldonk,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Hester E. de Melker,

  Affiliation Epidemiology and Surveillance Unit, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Elisabeth A. M. Sanders,

  Affiliation Department of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht, The Netherlands

  ⨯
• Guy A. M. Berbers,

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯
• Fiona R. M. van der Klis

  * E-mail: Fiona.van.der.Klis@rivm.nl

  Affiliation Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

  ⨯